RecruitingNCT06963853

Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis


Sponsor

Western Galilee Hospital-Nahariya

Enrollment

200 participants

Start Date

Aug 16, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective study aims to evaluate the diagnostic value and reliability of blood cultures obtained from different sources-central venous catheter (CVC), dialysis machine, and peripheral vein-in hemodialysis patients with suspected catheter-related bloodstream infections (CRBSIs). By comparing the timing and rates of bacterial growth from each site, the study seeks to identify the most accurate and timely method for diagnosing bloodstream infections in this patient population. In addition, the study will assess the dynamics of parathyroid hormone (PTH) levels during acute infections. Specifically, it will investigate whether a significant drop in PTH levels-and the rate of recovery following infection-correlates with adverse outcomes such as infectious complications, cardiovascular morbidity, or 90-day mortality. These findings may offer valuable prognostic insights and support improved monitoring and treatment strategies for dialysis patients experiencing infection.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \-

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood cultures will be obtained from three sources: 1. The central venous catheter (CVC), 2. The dialysis machine circuit, and 3. A peripheral vein

PTH levels during sepsis and compare them to baseline pre-infection levels, with serial follow-up of PTH values post-recovery.


Locations(1)

Galilee Medical Center

Nahariya, Israel, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06963853


Related Trials